Full Archive

Crazy but true

We don’t call this the wacky world of diabetes just because of the business of diabetes. This wackiness extends beyond deals done or not executed to the academic world. Largely we had given up on reporting about these stupid studies that show a connection between a woman’s breast size and diabetes or how there is a connection between red wine and diabetes. Yet we could not pass up this latest...

Poker or Solitaire?

According to a study published in the New England Journal of Medicine the iLet system from Beta Bionics. “In this 13-week, randomized trial involving adults and children with type 1 diabetes, use of a bionic pancreas was associated with a greater reduction than standard care in the glycated hemoglobin level.” What has most people excited about the system isn’t the results rather how easy the system is to use. While we would...

Are they ready?

Before we get started our thoughts and prayers go out to the residents of Florida as hurricane Ian bears down on the sunshine state. Now you might not think hurricane Ian is a diabetes related event but that’s where you would be wrong, as events such as these are even more difficult for anyone with diabetes. Think of this just for a moment as besides all the other things they must...

New design same issue

As much as GLP-1 therapy is changing the diabetes treatment paradigm insulin remains a cornerstone of that regimen. While GLP-1’s remain highly profitable and continue to see market share gains, thank you very much obesity. Insulin has become a boring commodity were price trumps performance. The two biggest innovations in insulin came when Sanofi launched Lantus which at the time was the first and only long-acting insulin. The other was...

Taking on more water

While the diabetes world gathers in Sweden the biggest news comes here in America where Medtronic diabetes continues to imitate the titanic by taking on more water. Already facing a multitude of issues, you can now add another as the FDA issued an URGENT field action over a cybersecurity issue. This issue impacts the 600 series including the 670g. Ironically at the same time Insulet, now the leading insulin pump company...

Just another meatball

Next week the diabetes world will gather yet again in Stockholm Sweden for another EASD. Unlike the highly anticipated ADA in NOLA, which turned out to be a huge disappointment, we have no expectations for EASD which is why we aren’t going. Why schlep across the pond to see more of the same old, same old. Why spend the time and money to trek across the pond when we are...

Value Destruction Continues

It was only a matter given all the issues at Medtronic, but investors have finally gotten fed up and have decided to exact their revenge. According to a post on the MassDevice website “The law firm of Kessler Topaz Meltzer & Check announced last week that it has sued the medtech giant in U.S. District in Minnesota, claiming securities fraud over how it disclosed insulin pump problems.” According to several sources this...